Human delta-lactoferrin is a transcription factor that enhances Skp1 (S-phase kinase-associated protein) gene expression

FEBS Journal

Volumn 274, Issue 8, 2007, Pages 2038-2053

  Mariller, Christophe ^a   Benaïssa, Monique ^a   Hardivillé, Stephan ^a   Breton, Mathilde ^a   Pradelle, Guillaume ^a   Mazurier, Joël ^a   Pierce, Annick ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Cell cycle progression; Delta lactoferrin; Proteasome; Skp1; Transcription factor

Indexed keywords

ARGINYLARGINYLSERYLASPARTYLTHREONYLSERYLLEUCYLTHREONYLTRYPTOPHYL ASPARAGINYLSERYLVALYLLYSYLGLYCYLLYSYLLYSINE; CULLIN; DELTA LACTOFERRIN; F BOX PROTEIN; LACTOFERRIN; MUTANT PROTEIN; PROTEASOME; S PHASE KINASE ASSOCIATED PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 1; SIGNAL PEPTIDE; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO; FEMALE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; REPORTER GENE; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION; UBIQUITINATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR LOCALIZATION SIGNALS; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION FACTORS;

EID: 34247116048     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05747.x     Document Type: Article

References (50)

1. Hershko A & Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67, 425-479.
2. Willems AR, Schwab M & Tyers M (2004) A hitch-hiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim Biophys Acta 1695, 133-170.
3. Ang XL & Wade Harper J (2005) SCF-mediated protein degradation and cell cycle control. Oncogene 24, 2860-2870.
4. Siebert PD & Huang BC (1997) Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci USA 94, 2198-2203.
5. Benaissa M, Peyrat JP, Hornez L, Mariller C, Mazurier J & Pierce A (2005) Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer 114, 299-306.
6. Liu D, Wang X, Zhang Z & Teng CT (2003) An intronic alternative promoter of the human lactoferrin gene is activated by Ets. Biochem Biophys Res Commun 301, 472-479.
7. Breton M, Mariller C, Benaissa M, Caillaux K, Browaeys E, Masson M, Vilain JP, Mazurier J & Pierce A (2004) Expression of delta-lactoferrin induces cell cycle arrest. Biometals 17, 325-329.
8. Penco S, Scarfi S, Giovine M, Damonte G, Millo E, Villaggio B, Passalacqua M, Pozzolini M, Garre C & Benatti U (2001) Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 34, 151-159.
9. van Berkel PH, Geerts ME, van Veen HA, Mericskay M, de Boer HA & Nuijens JH (1997) N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J 328(1), 145-151.
10. Garre C, Bianchi-Scarra G, Sirito M, Musso M & Ravazzolo R (1992) Lactoferrin binding sites and nuclear localization in K562(S) cells. J Cell Physiol 153, 477-482.
11. Baker EN, Baker HM & Kidd RD (2002) Lactoferrin and transferrin: functional variations on a common structural framework. Biochem Cell Biol 80, 27-34.
12. Baker EN & Baker HM (2005) Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 62, 2531-2539.
13. Hutchens TW, Magnuson JS & Yip TT (1989) Interaction of human lactoferrin with DNA: one-step purification by affinity chromatography on single-stranded DNA-agarose. Pediatr Res 26, 618-622.
14. Hutchens TW, Henry JF, Yip TT, Hachey DL, Schanler RJ, Motil KJ & Garza C (1991) Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milk-fed preterm infants. Evaluation by stable isotopic enrichment. Pediatr Res 29, 243-250.
15. Britigan BE, Lewis TS, Waldschmidt M, McCormick ML & Krieg AM (2001) Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J Immunol 167, 2921-2928.
16. Kanyshkova TG, Semenov DV, Buneva VN & Nevinsky GA (1999) Human milk lactoferrin binds two DNA molecules with different affinities. FEBS Lett 451, 235-237.
17. He J & Furmanski P (1995) Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373, 721-724.
18. Son KN, Park J, Chung CK & Chung DK, Yu DY, Lee KK & Kim J (2002) Human lactoferrin activates transcription of IL-1beta gene in mammalian cells. Biochem Biophys Res Commun 290, 236-241.
19. Legrand D, Elass E, Pierce A & Mazurier J (2004) Lactoferrin and host defence: an overview of its immunomodulating and anti-inflammatory properties. Biometals 17, 225-229.
20. Legrand D, Elass E, Carpentier M & Mazurier J (2005) Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 62, 2549-2559.
21. Giancotti V (2006) Breast cancer markers. Cancer Lett 243, 145-159.
22. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G & Boilly-Marer Y (1999) Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74, 486-498.
23. Xiao Y, Monitto CL, Minhas KM & Sidransky D (2004) Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin Cancer Res 10, 8683-8686.
24. Oh SM, Hahm DH, Kim IH & Choi SY (2001) Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J Biol Chem 276, 42575-42579.
25. Fujita K, Matsuda E, Sekine K, Iigo M & Tsuda H (2004) Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Lett 213, 21-29.
26. Fujita K, Matsuda E, Sekine K, Iigo M & Tsuda H (2004) Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25, 1961-1966.
27. Ward PP, Paz E & Conneely OM (2005) Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 62, 2540-2548.
28. Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW & Elledge SJ (1996) SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263-274.
29. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C, Koepp DM, Elledge S, Pagana M et al. (2002) Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416, 703-709.
30. Zhang H, Kobayashi R, Galaktionov K & Beach D (1995) p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82, 915-925.
31. Carrano AC, Eytan E, Hershko A & Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1, 193-199.
32. Marti A, Wirbelauer C, Scheffner M & Krek W (1999) Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1, 14-19.
33. Tsvetkov LM, Yeh KH, Lee SJ, Sun H & Zhang H (1999) p27 (Kip1) ubiquitination and degradation is regulated by the SCF (Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9, 661-664.
34. Kitagawa K & Hieter P (2001) Evolutionary conservation between budding yeast and human kinetochores. Nat Rev Mol Cell Biol 2, 678-687.
35. Lehmann A & Toda T (2004) Fission yeast Skp1 is required for spindle morphology and nuclear membrane segregation at anaphase. FEBS Lett 566, 77-82.
36. Piva R, Liu J, Chiarle R, Podda A, Pagano M & Inghirami G (2002) In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation. Mol Cell Biol 22, 8375-8387.
37. Wirbelauer C, Sutterluty H, Blondel M, Gstaiger M, Peter M, Reymond F & Krek W (2000) The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J 19, 5362-5375.
38. Mantel C, Miyazawa K & Broxmeyer HE (1994) Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity. Adv Exp Med Biol 357, 121-132.
39. Bennett RM, Bagby GC & Davis J (1981) Calcium-dependent polymerization of lactoferrin. Biochem Biophys Res Commun 101, 88-95.
40. Nakai K & Horton P (1999) PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 24, 34-36.
41. Panella TJ, Liu YH, Huang AT & Teng CT (1991) Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer. Cancer Res 51, 3037-3043.
42. Liu LH, Gladwell W & Teng CT (2002) Detection of exon polymorphisms in the human lactoferrin gene. Biochem Cell Biol 80, 17-22.
43. Teng C, Gladwell W, Raphiou I & Liu E (2004) Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals 17, 317-323.
44. Lefebvre T, Alonso C, Mahboub S, Dupire MJ, Zanetta JP, Caillet-Boudin ML & Michalski JC (1999) Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. Biochim Biophys Acta 1472, 71-81.
45. Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
46. Harlow E & Lane D (1988) Antibodies: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. Fillebeen C, Mitchell V, Dexter D, Benaissa M, Beauvillain J, Spik G & Pierce A (1999) Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Brain Res Mol Brain Res 72, 183-194.
48. Robbins J, Dilworth SM, Laskey RA & Dingwall C (1991) Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64, 615-623.
49. Jans DA, Briggs LJ, Gustin SE, Jans P, Ford S & Young IG (1997) A functional bipartite nuclear localisation signal in the cytokine interleukin-5. FEBS Lett 406, 315-320.
50. Efthymiadis A, Shao H, Hubner S & Jans DA (1997) Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo and in vitro. A comparison with the SV40 large T-antigen NLS. J Biol Chem 272, 22134-22139.